Are you Dr. Chun?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 50 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
10945 Le Conte Ave
Ste 2333
Los Angeles, CA 90095Phone+1 310-206-1214Fax+1 310-206-3289
Summary
- Dr. Patrick Chun, MD is an oncologist in Los Angeles, California. He is currently licensed to practice medicine in California.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2008 - 2012
Brown UniversityResidency, Internal Medicine, 2005 - 2008
Michigan State University College of Human MedicineClass of 2004
Certifications & Licensure
CA State Medical License 2008 - 2026
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Study to Evaluate the Efficacy and Safety of Andecaliximab Combined With Nivolumab Versus Nivolumab Alone in Adults With Unresectable or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma Start of enrollment: 2016 Sep 01
- A Study of ZN-c5 in Subjects With Breast Cancer Start of enrollment: 2018 Dec 08
Publications & Presentations
PubMed
- 64 citationsSynergistic Effects of Gemcitabine and Gefitinib in the Treatment of Head and Neck CarcinomaPatrick Y. Chun, Felix Y. Feng, Ashley M. Scheurer, Mary A. Davis, Theodore S. Lawrence
Cancer Research. 2006-01-15 - 61 citationsRole of epidermal growth factor receptor degradation in gemcitabine-mediated cytotoxicity.Felix Y. Feng, Sooryanarayana Varambally, Scott A. Tomlins, Patrick Y. Chun, Carlos López
Oncogene. 2007-05-17 - 42 citationsEffect of epidermal growth factor receptor inhibitor class in the treatment of head and neck cancer with concurrent radiochemotherapy in vivo.Felix Y. Feng, Carlos López, Daniel P. Normolle, Sooryanarayana Varambally, Xiaoxin Li
Clinical Cancer Research. 2007-04-15
